 WESTLAKE VILLAGE, Calif., Jan. 04, 2021 GLOBE NEWSWIRE -- MannKind Corporation Nasdaq: MNKD, a company focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases, announced today that its Chief Executive Officer, Michael Castagna, PharmD, will participate in a Fireside Chat at the H.C. Wainwright Bioconnect 2021 Conference which will be available on demand starting on January 11, 2021 at 6:00 am ET. Interested parties can access a link to the on demand webcast of the presentation from the Events Presentations section of the Companys website at r p.com. The webcast replay will remain available for 14 days following the live presentation. 